# Minerva First No-Mutation Intake Execution Phase Progress v0.1

## Current Goal

Create deterministic no-mutation intake execution metadata and a review-only evidence envelope while preserving all no-action boundaries.

## Current Phase

Controlled first no-mutation intake execution / evidence envelope.

## Current Estimated Progress Before Slice

0% complete for the first no-mutation intake execution phase.

## Expected Progress After Slice

Approximately 55-65% complete.

## Completed Prior Work

- Governed Evidence Intake Phase Closeout / Intake Runbook v0.1.
- Controlled Evidence Intake Dry-Run Phase Closeout / No-Mutation Ledger v0.1.
- Controlled Evidence Intake Authorisation Gate / First No-Mutation Intake Candidate v0.1.
- Controlled Evidence Intake First Candidate Review / Authorisation Closeout v0.1.

## Work Added By This Slice

- Controlled first no-mutation intake execution service.
- Controlled no-mutation intake evidence envelope service.
- Execution model documentation.
- Evidence envelope documentation.
- Phase progress documentation.
- Focused tests for deterministic execution, review-only evidence envelope preparation, no-action flags, and blocked overstatement boundaries.

## Remaining Work

- Review the prepared evidence envelope.
- Decide whether to create a separate durable-ingestion authorisation gate.
- Keep durable ingestion, corpus mutation, Code Evidence ingestion, DB access, DB writes, live retrieval, live LLM use, final answer generation, chat exposure, endpoint exposure, runtime integration, deployment, and production deferred unless explicitly authorised in a later slice.

## Quality Guardrails

This phase remains local, deterministic, service/docs/tests only. It has no API route, UI, DB connection, migration, corpus write, evidence store write, Code Evidence ingestion, retrieval backend change, LLM call, final answer generation, workforce-platform change, analytics runtime integration, deployment readiness claim, runtime readiness claim, or production readiness claim.

## Recommended Next Slice

Controlled No-Mutation Evidence Envelope Review Closeout / Durable-Ingestion Decision Gate v0.1.

## Developer Handoff

Continue from approximately 55-65% complete. Treat the execution and envelope outputs as review metadata only; do not treat future ingestion candidate metadata as durable ingestion authorisation.
